Trial Profile
Effects of Vildaglipin and Glimepiride on Glycemic Variability and on Cardiovascular parameters in patients with type 2 diabetes in failure with basal insulin EFFETTI DEL VILDAGLIPTIN E DELLA GLIMEPIRIDE SULLA VARIABILITA? GLICEMICA E SUI PARAMETRI CARDIOVASCOLARI IN PAZIENTI AFFETTI DA DIABETE DI TIPO 2 IN FALLIMENTO CON INSULINA BASALE
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2014
Price :
$35
*
At a glance
- Drugs Glimepiride (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 02 Jul 2014 New trial record